SIK2 and cancer: Given its involvement in metabolic pathways and potential roles in cancer progression, SIK2 expression may indirectly influence tissue characteristics, aiding in risk stratification, treatment selection and prognosis assessment, thus positioning SIK2 as a promising prognostic marker and drug target.